Pharming Group
(NASDAQ) PHAR
Pharming Group Financials at a Glance
Market Cap
$909.21M
Revenue (TTM)
$369.38M
Net Income (TTM)
$12.33M
EPS (TTM)
$0.17
P/E Ratio
72.36
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$12.89
Volume
3,253
Open
$12.93
Price
$12.89
Volume
3,253
Open
$12.93
Previous Close
$12.87
Daily Range
$12.82 - $13.00
52-Week Range
$9.54 - $21.34
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$12.89
Volume
3,253
Open
$12.93
Previous Close
$12.87
Daily Range
$12.82 - $13.00
52-Week Range
$9.54 - $21.34
Estimated Earnings Date
Jul 30, 2026
PHAR News
PHAR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pharming Group
Industry
Biotechnology
Sector
Health CareCEO
Fabrice Chouraqui, MBA
Website
www.pharming.comHeadquarters
Leiden, 2333 CR, NL
PHAR Financials
Key Financial Metrics (TTM)
Gross Margin
88%
Operating Margin
6%
Net Income Margin
3%
Return on Equity
5%
Return on Capital
6%
Return on Assets
3%
Earnings Yield
1.38%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$909.21M
Shares Outstanding
70.63M
Volume
3.25K
Avg. Volume
13.91K
Financials (TTM)
Gross Profit
$331.56M
Operating Income
$20.88M
EBITDA
$31.70M
Operating Cash Flow
$50.07M
Capital Expenditure
-$751.09K
Free Cash Flow
$49.31M
Cash & ST Invst.
$179.81M
Total Debt
$115.78M
Pharming Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$72.45M
-8.4%
Gross Profit
$65.80M
-7.0%
Gross Margin
90.83%
N/A
Market Cap
$909.21M
N/A
Market Cap/Employee
$2.25M
N/A
Employees
404
N/A
Net Income
-$5.21M
+64.6%
EBITDA
$1.06M
+125.8%
Quarterly Fundamentals
Total Cash
$170.90M
+59.3%
Total Debt
$116.21M
-2.5%
Accounts Receivable
$60.03M
+26.4%
Inventory
$64.58M
+8.8%
Long Term Debt
$108.06M
-2.1%
Short Term Debt
$8.15M
-7.3%
Return on Assets
2.55%
N/A
Return on Invested Capital
6.24%
N/A
Free Cash Flow
$1.39M
+2578.6%
Operating Cash Flow
$1.63M
+601.2%